These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 3544744)
1. [Prophylactic effect of etretinate on the recurrence of superficial bladder tumors--results of a randomized control study]. Yoshida O; Miyakawa M; Watanabe H; Mishina T; Okajima E; Hirao Y; Matushima M; Nihira H; Nakatsu H Hinyokika Kiyo; 1986 Sep; 32(9):1349-58. PubMed ID: 3544744 [TBL] [Abstract][Full Text] [Related]
2. [Etretinate in the prevention of recurrences of superficial bladder tumors. Clinical trial using the double-blind method]. Charbit L; Mangin P; Rognin C; Cukier J J Urol (Paris); 1983; 89(4):247-9. PubMed ID: 6350479 [TBL] [Abstract][Full Text] [Related]
3. [Short-term intravesical instillation of pirarubicin (THP) in prophylactic treatment after transurethral resection of superficial bladder tumor]. Kuroda K; Ishii N; Fukasawa K; Shirai M; Tajima M; Matsushima M; Miura K; Takanami M; Matsuhashi M; Kuwabara T; Matsumoto H; Sugita M Hinyokika Kiyo; 1998 Aug; 44(8):547-52. PubMed ID: 9783189 [TBL] [Abstract][Full Text] [Related]
4. [A randomized study on intravesical pirarubicin (THP) chemoprophylaxis of recurrence after transurethral resection of superficial bladder cancer]. Miki T; Nonomura N; Kojima Y; Okuyama A; Nakano E; Kiyohara H; Fujioka H; Koide T; Wakatsuki A; Kuroda H; Sugao H; Seguti T; Takeyama M; Yamaguchi S Hinyokika Kiyo; 1997 Dec; 43(12):907-12. PubMed ID: 9488944 [TBL] [Abstract][Full Text] [Related]
5. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence]. Ding GQ; Shen ZJ; Lu J; Jin XD; Chen J; Shi SF Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1457-60. PubMed ID: 16318813 [TBL] [Abstract][Full Text] [Related]
6. [Prophylactic effect of pirarubicin (THP) on postoperative recurrence of superficial bladder cancer in terms of intravesical retention time]. Nonomura N; Nishimura K; Okuyama A; Miki T; Kishimoto T; Kiyohara H; Wakatsuki A; Fujioka H; Kuroda H; Nakano E; Takeyama M; Koide T; Yamaguchi S Hinyokika Kiyo; 2001 May; 47(5):315-9. PubMed ID: 11433751 [TBL] [Abstract][Full Text] [Related]
7. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer. Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510 [TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder. Koga H; Kuroiwa K; Yamaguchi A; Osada Y; Tsuneyoshi M; Naito S J Urol; 2004 Jan; 171(1):153-7. PubMed ID: 14665865 [TBL] [Abstract][Full Text] [Related]
9. [Continuous intravesical instillation of epirubicin immediately after transurethral resection of superficial bladder cancer: a prospective controlled study]. Maekawa S; Suzuki H; Ohkubo K; Aoki Y; Okada T; Maeda H; Ogura K; Arai Y Hinyokika Kiyo; 2000 May; 46(5):301-6. PubMed ID: 10876750 [TBL] [Abstract][Full Text] [Related]
10. [Prophylactic combination therapy after TUR of superficial bladder cancer]. Ao T; Uchida T; Yokoyama E; Kawakami T; Adachi K; Mashimo S; Endo T; Koshiba K Hinyokika Kiyo; 1993 Nov; 39(11):987-91. PubMed ID: 7505523 [TBL] [Abstract][Full Text] [Related]
11. [Oral administration of 5-fluorouracil (5-FU) with intravesical chemotherapy as prophylaxis against recurrence of superficial bladder tumors]. Tanaka T; Yuasa M; Yamamoto A; Kawanishi Y; Numata A; Imagawa A Gan No Rinsho; 1986 Sep; 32(11):1439-42. PubMed ID: 3773272 [TBL] [Abstract][Full Text] [Related]
12. [A randomized study of prophylactic intravesical instillation of pirarubicin (THP) prior to transurethral resection of superficial bladder cancer]. Hashimura T; Shirahase T; Inoue T; Yamasaki T; Terada N; Ogura K; Arai Y; Hida S; Ueda T Hinyokika Kiyo; 2005 Jul; 51(7):439-42. PubMed ID: 16119805 [TBL] [Abstract][Full Text] [Related]
13. The immunomodulating effect of interferon-gamma intravesical instillations in preventing bladder cancer recurrence. Giannopoulos A; Constantinides C; Fokaeas E; Stravodimos C; Giannopoulou M; Kyroudi A; Gounaris A Clin Cancer Res; 2003 Nov; 9(15):5550-8. PubMed ID: 14654535 [TBL] [Abstract][Full Text] [Related]
14. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study. Hinotsu S; Akaza H; Isaka S; Kanetake H; Kubota Y; Kuroda M; Shinohara N; Shinka T; Tachibana M; Naito S; Hirao Y; Urology; 2006 Mar; 67(3):545-9. PubMed ID: 16527576 [TBL] [Abstract][Full Text] [Related]
15. Early and large-dose intravesical instillation of epirubicin to prevent superficial bladder carcinoma recurrence after transurethral resection. Mitsumori K; Tsuchiya N; Habuchi T; Li Z; Akao T; Ohyama C; Sato K; Kato T BJU Int; 2004 Aug; 94(3):317-21. PubMed ID: 15291859 [TBL] [Abstract][Full Text] [Related]
16. [An experience of OK-432 intradermal administration in superficial bladder tumors]. Tsujihashi H; Akiyama T; Kurita T; Iguchi M; Uejima S; Kataoka K; Minakata S; Kitagawa M; Sangen H Hinyokika Kiyo; 1988 Dec; 34(12):2111-4. PubMed ID: 3239522 [TBL] [Abstract][Full Text] [Related]
17. [Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes]. Iturralde Codina A; Beyríe Tamayo W; Gozá León F; Muñoz YI Arch Esp Urol; 2004; 57(6):606-18. PubMed ID: 15382436 [TBL] [Abstract][Full Text] [Related]
18. [Postoperative prophylactic intravesical instillation of tetrahydropyranyl-adriamycin (THP) for superficial bladder cancer]. Kanayama H; Yokota K; Kurokawa Y; Kagawa S; Yokozeki H; Inai T; Ogawa I; Akazawa S; Hashimoto H; Mizuta K Gan To Kagaku Ryoho; 1999 Apr; 26(5):651-5. PubMed ID: 10234296 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial. Goebell PJ; Otto T; Suhr J; Rübben H J Urol; 2002 Jul; 168(1):72-5. PubMed ID: 12050495 [TBL] [Abstract][Full Text] [Related]
20. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. Divrik RT; Yildirim U; Zorlu F; Ozen H J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]